A. Manika (Pylaia (Thessaloniki), Greece), A. Rahman (Essex, United Kingdom)
Late Breaking Abstract - Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results N. Lytvynenko (Kyiv, Ukraine), M. Pogrebna (Kyiv, Ukraine), J. Senko (Kyiv, Ukraine), L. Protsyk (Kyiv, Ukraine), O. Chobotar (Kyiv, Ukraine), N. Grankina (Kyiv, Ukraine), M. Gumenuk (Kyiv, Ukraine)
|  |
Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment D. Butov (Kharkiv, Ukraine), Y. Feshchenko (Kiev, Ukraine), M. Kuzhko (Kiev, Ukraine), M. Gumenuik (Kiev, Ukraine), Y. Kateryna (Kharkiv, Ukraine), A. Tkachenko (Kharkiv, Ukraine), N. Nekrasova (Kharkiv, Ukraine), N. Gulchuk (Kiev, Ukraine), T. Tlustova (Kiev, Ukraine), T. Butova (Kharkiv, Ukraine)
|  |
Homeless with TB: a” long race” vulnerable group (20 years review) A. Sorete Arbore (Iasi, Romania), V. Cojocariu (Iasi, Romania)
|   |
Endobronchial valve application in tuberculosis patients with low treatment adherence D. Krasnov (Novosibirsk, Russian Federation), P. Fadeev ( Chita, Russian Federation), I. Felker (Novosibirsk, Russian Federation), V. Krasnov (Novosibirsk, Russian Federation)
|  |
Tuberculosis and gastrectomy : A Nationwide Population-based Matched Cohort Study W. Jung (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), B. Kim (Seoul, Republic of Korea), E. Lee (Seoul, Republic of Korea), K. In (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
|  |
Frequency of relapse rates in rifampicin-resistant tuberculosis in operated patients. T. Bagdasaryan (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
|  |
Changes in body composition and strength during initial treatment in malnourished patients with tuberculosis Y. De Reus (Groningen, Netherlands), L. Ter Beek (Groningen, Netherlands), T. Van Der Werf (Groningen, Netherlands), O. Akkerman (Groningen, Netherlands)
|   |
Adverse events in patients with MDR TB, treated by three types of the chemotherapy regimens O. Rodina (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation)
|  |
The impact of bedaquiline and delamanid containing regimens on liver function in patients multi-infected with pulmonary DR-TB, HIV and viral hepatitis N. Kiria (Tbilisi, Georgia), Z. Avaliani (Tbilisi, Georgia), N. Bolokadze (Tbilisi, Georgia), N. Kiria (Tbilisi, Georgia), L. Mikiashvili (Tbilisi, Georgia)
|   |
Statin with standard antituberculosis regimen and mortality in hospitalized pulmonary tuberculosis T. Jeeraaumponwat (Khon Kaen, Thailand)
|   |
DOT-VOT Implementation of Tuberculosis Patients between 2012-2018 F. Duyar Agca (Ankara, Turkey), A. I?nan Süer (Ankara, Turkey), G. Çimen Beyaz (Ankara, Turkey)
|  |
Rifampicin-resistant tuberculosis in Singapore, 2005 to 2018 S. Gan (Singapore, Singapore), L. Lim (Singapore, Singapore), Y. Wang (Singapore, Singapore), C. Chee (Singapore, Singapore)
|  |
New approaches to MDR/XDR TB chemotherapy in children and adolescents A. Khiteva (Moscow, Russian Federation), L. Panova (Moscow, Russian Federation), E. Ovsyankina (Moscow, Russian Federation), E. Krushinskaya (Moscow, Russian Federation)
|  |
Bedaquiline in the treatment of multidrug-resistant tuberculosis: a subanalysis in Korean population J. Kim (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), O. Kwon (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), S. Hwang (Suwon, Republic of Korea)
|   |
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey G. Bothamley (London, United Kingdom), E. Andre (Leuven, Belgium), L. Kuksa (Riga, Latvia), L. Barkana (Riga, Latvia), J. Keane (Dublin, Ireland), N. Veziris (Paris, France), R. Van Crevel (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands), M. Jankovic (Zagreb, Croatia), O. Schoch (St. Gallen, Switzerland), J. Zellweger (Berne, Switzerland), T. Vasankari (Helsinki, Finland), F. Eyuboglu (Ankara, Turkey), R. Holland (Utrecht, Netherlands), J. Normark (Umeå, Sweden), R. Macedo (Lisbon, Portugal), M. Korzeniewska (Warsaw, Poland), Z. Nanovoc (Skopje, North Macedonia), D. Butov (Kharkiv, Ukraine), O. Akkerman (Groningen, Netherlands), O. Kirakosyan (Yerevan, Armenia), I. Solovic (Vysne Hagy, Slovakia), A. Calcagno (Torino, Italy), K. Kruczak (Krakow, Poland), J. Garcia Garcia (Aviles, Spain), A. Sanchez Montalva (Barcelona, Spain), A. Dyatlov (Moscow, Russian Federation), A. Starshinova (St. Petersburg, Russian Federation), S. Kulcitkaia (Chisinau, Republic of Moldova), T. Lillebaek (Copenhagen, Denmark), L. Wiese (Roskilde, Denmark), H. Hafizi (Tirana, Albania), D. Papaventis (Athens, Greece), E. Heldel (Oslo, Norway), T. Arnesen (Oslo, Norway), J. Lanoix (Amiens, France), E. Chiappini (Florence, Italy), C. Wejse (Aarhus, Denmark), K. Manika (Thessaloniki, Greece), D. Pesut (Belgradei, Republic of Serbia), N. Wetzstein (Frankfurt, Germany), A. Skrahina (Minsk, Belarus), H. Flick (Graz, Austria), M. Arias (Oviedo, Spain), O. Konstantynovska (Kharkiv, Ukraine), J. Millet (Barcelona, Spain), M. Bakker (Rotterdamona, Netherlands), C. Lange (Borstel, Germany)
|  |
Spatio-temporal distribution of HIV-tuberculosis coinfection in brazilian macroregions, between 2003 and 2016 V. Teotonio (João Pessoa, Brazil), J. Teódulo (João Pessoa, Brazil), G. Sousa (João Pessoa, Brazil), J. Sousa (Santos, Brazil), C. Barros (Santos, Brazil)
|   |
Unmasking the hidden tuberculosis mortality burden in a large postmortem study in Mozambique. A. Garcia-Basteiro (Barcelona, Spain), J. Hurtado (Barcelona, Spain), P. Castillo (Barcelona, Spain), F. Fernandes (Barcelona, Spain), M. Navarro (Barcelona, Spain), L. Lovane (Maputo, Mozambique), I. Casas (Barcelona, Spain), L. Quinto (Barcelona, Spain), D. Jordao (Maputo, Mozambique), M. Ismail (Maputo, Mozambique), C. Lorenzoni (Maputo, Mozambique), C. Carrilho (Maputo, Mozambique), A. Sanz (Barcelona, Spain), N. Rakislova (Barcelona, Spain), A. Mira (Barcelona, Spain), M. Alvarez-Martínez (Barcelona, Spain), A. Cossa (Maputo, Mozambique), F. Cobelens (Amsterdam, Netherlands), I. Mandomando (Maputo, Mozambique), J. Vila (Barcelona, Spain), Q. Bassat (Barcelona, Spain), C. Menéndez (Barcelona, Spain), J. Ordi (Barcelona, Spain), M. Martínez (Barcelona, Spain)
|  |